Analysts Offer Predictions for MRKR FY2024 Earnings
Marker Therapeutics, Inc. (NASDAQ:MRKR – Free Report) – Analysts at Brookline Capital Management issued their FY2024 EPS estimates for Marker Therapeutics in a research note issued to investors on Monday, February 10th. Brookline Capital Management analyst L. Cann expects that the company will post earnings of ($0.25) per share for the year. Brookline Capital Management […]
Marker Therapeutics, Inc. (NASDAQ:MRKR – Free Report) – Analysts at Brookline Capital Management issued their FY2024 EPS estimates for Marker Therapeutics in a research note issued to investors on Monday, February 10th. Brookline Capital Management analyst L. Cann expects that the company will post earnings of ($0.25) per share for the year. Brookline Capital Management […]
